Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea Faces FTA Dilemma As It Seeks To Balance Pricing Concerns

Executive Summary

South Korean pharma firms are facing a dilemma due to the country's Free Trade Agreement renegotiations with the US, under which drug pricing is not the only difficulty being raised by foreign companies seeking reforms. Despite ongoing government efforts to attract global pharma companies, such firms are also still finding it tough to search for alliance partners in the country.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC100695

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel